TY - JOUR T1 - Cost effectiveness of ranibizumab vs aflibercept vs bevacizumab for the treatment of macular oedema due to central retinal vein occlusion: the LEAVO study JO - PharmacoEconomics UR - http://eprints.whiterose.ac.uk/173442/ PY - 2021/04/26 AU - Pennington R AU - Alshreef A AU - Flight L AU - Metry A AU - Poku E AU - Hykin P AU - Sivaprasad S AU - Prevost AT AU - Vasconcelos JC AU - Murphy C AU - Kelly J et al ED - DO - DOI: 10.1007/s40273-021-01026-5 PB - Springer Y2 - 2025/04/13 ER -